✦ LIBER ✦

Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis A feasibility and health economic study in an outpatient setting

✍ Scribed by P. LINDMARKER; M. HOLMSTRÖM; Swedish Venous Thrombosis Dalteparin Trial Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicentre comparison of once-daily s

✍ K. LUOMANMÄKI; S. GRANKVIST; C. HALLERT; I. JAURO; K. KETOLA; H. C. KIM; H. KIVI 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Once-Daily Enoxaparin in The Outpatient

✍ Beng H. Chong; Tim A. Brighton; Ross I. Baker; Peter Thurlow; Choon H. Lee 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 507 KB

A Randomized Trial Comparing 2 Low-Molec

✍ P.S. Wells; D.R. Anderson; M.A. Roger 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

A randomized, double blind study of a lo

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A pilot study of central venous catheter

✍ M. J. KOVACS; S. R. KAHN; M. RODGER; D. R. ANDERSON; R. ANDREOU; J. E. MANGEL; B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

Comparison of a low molecular weight hep

✍ The European Fraxiparin Study (EFS) Group; Professor A. Encke; Professor K. Bred 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 718 KB